Delivery Order SPE2DB20D3103-SPE2DB22FP4U9
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,469.14 Firm Fixed Price Delivery Order is for the supply of 4564690797 - TELMISARTAN 20 MG TABLET 30S to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,058.88 Firm Fixed Price Delivery Order is for the supply of 4562879875 - TELMISARTAN 20 MG TABLET 30S, with a period of performance through November 22, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TELMISARTAN 20 MG TABLET 30S. The single-award contract has a ceiling value of $1,006.22 and runs through December 18, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $6,190.82, is for the delivery of 4562659563 TELMISARTAN 20 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of November 1, 2023 and is a Firm Fixed Price Delivery Order. This award is part of Amerisourcebergen's broader $999,999,999...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,702.60, is for the delivery of TELMISARTAN 20 MG TABLET 30S, a cardiovascular medication. This is a Delivery Order contract with a Firm Fixed Price pricing type, with a completion date of July 18, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
- This federal contract award, with the ID SPE2DB22D1200|SPE2DB24FN3CX, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4564911228 TELMISARTAN 20 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, has a ceiling value of $1,504.14, and is set to expire on June 17, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,391.30 Delivery Order contract is for the supply of 4560664400 TELMISARTAN 80 MG TABLET 30S. The contract has an ultimate completion date of April 21, 2023 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation, indicating...
- This federal contract award, valued at $1,299.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order contract with a Firm Fixed Price pricing type and an ultimate completion date of June 18, 2024. The contract is for the provision of TELMISARTAN 20 MG TABLET 30S, a pharmaceutical product, to support federal healthcare programs. This award is part of a larger...
- This federal contract award SPE2DB20D3103|SPE2DB25FM1K0 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,330.64 firm fixed-price delivery order is for the supply of 4566802956 - TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of December 30, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
- This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $3,466.67 firm fixed price delivery order is for the supply of 4564267478 - TELMISARTAN 20 MG TABLET 30S, a pharmaceutical product. The contract does not have a set-aside designation. The award is issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FP4U9Delivery Order
This federal contract award, with ID SPE2DB20D3103|SPE2DB22FP4U9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,122.60, is for the delivery of 4558072627 TELMISARTAN 20 MG TABLET 30S. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 12, 2022. This contract award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 8/11/22 |